Total Visits

Views
IMscin001 ...26

Total Visits Per Month

June 2023July 2023August 2023September 2023October 2023November 2023December 2023
IMscin001 ...00152900

File Visits

Views
imscin001_part_2_a_randomised_phase_iii_open_label_multicentre_study_examining_pharmacokinetics_efficacy_immunogenicity_safety_atezolizumab_subcutaneous_2023.pdf8

Top country views

Views
United States17
France3
South Korea3
Germany2
Spain1

Top cities views

Views
Boydton4
Paris3
Barcelona1
Chicago1
Rietheim-Weilheim1